Aim Our study aimed to identify Skeletal Muscle Mass Index (SMMI) cut-off values for
sarcopenia diagnosis in our population and determine the prevalance of sarcopenia, and to …

Background The reported prevalence of sarcopenia ranges widely depending on its
definition criterion. European Working Group on Sarcopenia in Older People (EWGSOP) …

Abstract Objectives The European Working Group on Sarcopenia in Older People
(EWGSOP) has proposed different methods and cut-off points for the three parameters that …

Introduction A muscle mass normalized for height 2 (MMI) or for body weight (SMI) below
2SD under the mean for a young population defines sarcopenia. This study aimed at setting …

The revised European consensus defined sarcopenia as a progressive and generalized
skeletal muscle disorder that is associated with an increased likelihood of adverse outcomes …

Background & aims Sarcopenia is a muscle disorder associated with loss of muscle mass,
strength and function. Early screening, diagnosis and treatment may improve outcome in …

Background/objectives The definition of sarcopenia remains a matter of discussion and
there is no globally accepted consensus for its diagnosis. The aim of this study was to …

The study aimed to describe the prevalence of sarcopenia and discussed the applicability of
different diagnostic criteria in Chinese older adults. 286 Chinese adults (136 men and 150 …

Introduction Sarcopenia is a muscle disease that is associated with a decline in muscle
strength and function. When this condition coexists with sarcopenia, it is characterized as …

Sarcopenia, characterized by low muscle mass and function, results in frailty, comorbidities
and mortality. However, its prevalence varies according to the different criteria used in its …